Home
>
US Stocks
>
Intersect ENT Inc
Intersect ENT Inc
XENT

Intersect ENT Inc (XENT)

$26.952.43%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
26.88
Today Low/High
26.84 / 27.06
52 Week Low/High
$14.68 / $28.17
Market Cap
$910.49M

Company Details

Intersect ENT is a global ear, nose and throat medical technology leader dedicated to transforming patient care. The Company's steroid releasing implants are designed to provide mechanical spacing and deliver targeted therapy to the site of disease. In addition, Intersect ENT is continuing to expand its portfolio of products based on the Company's unique localized steroid releasing technology and is committed to broadening patient access to less invasive and more cost-effective care. In October 2020, Intersect ENT acquired Fiagon AG Medical Technologies, a global leader in electromagnetic surgical navigation solutions with an expansive portfolio of ENT product offerings, including the VENSURE sinus balloon, that complement the Company's PROPEL® and SINUVA® sinus implants and extend its geographic reach.
Organisation
Intersect ENT Inc
Headquaters
Menlo Park, California, US
Employees
406
Industry
Health Technology
CEO
Thomas West

Discover more

Frequently Asked Questions

What is Intersect ENT Inc (XENT) share price today?

Can Indians buy Intersect ENT Inc (XENT) shares?

How can I buy Intersect ENT Inc (XENT) shares from India?

Can Fractional shares of Intersect ENT Inc (XENT) be purchased?

What are the documents required to start investing in Intersect ENT Inc (XENT) stocks?

We are a SEBI registered investement advisor